N/A
Manufactured by GE Healthcare
15,311 FDA adverse event reports analyzed
Last updated: 2026-04-14
IOHEXOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by GE Healthcare. The most commonly reported adverse reactions for IOHEXOL include URTICARIA, PRURITUS, DYSPNOEA, SNEEZING, ERYTHEMA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for IOHEXOL.
Out of 7,806 classified reports for IOHEXOL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 15,311 FDA FAERS reports that mention IOHEXOL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include URTICARIA, PRURITUS, DYSPNOEA, SNEEZING, ERYTHEMA, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list GE Healthcare in connection with IOHEXOL. Always verify the specific product and NDC with your pharmacist.